Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec)
Go back to Amgen Receives CHMP Positive Opinion For IMLYGIC™ (Talimogene Laherparepvec)| Amgen Inc (NASDAQ: AMGN) | Delayed: 410.14 +4.10 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $406.04 | 52 Week High | $176.85 | |||
| Open | $408.25 | 52 Week Low | $133.64 | |||
| Day High | $410.52 | P/E | 61.77 | |||
| Day Low | $404.19 | EPS | $6.64 | |||
| Volume | 554,432 | |||||

